-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels: Introduction to the Features of the Inoculation Platform for Hematology Tumor Modeling System
Author:
InnoModels
Release time:
2024-03-07
In the field of cancer research, animal models are indispensable tools that provide researchers with experimental environments that simulate human disease processes. As a leader in this field, the hematological tumor model system inoculation platform of InnoModels Biotechnology, with its unique features and advantages, opens up a new path for hematological tumor research.
Highly simulated human environment
The inoculation platform of InnoModels Blood Tumor Model System focuses on simulating the tumor growth environment in the human body. Through advanced bioengineering technology, the platform is able to accurately simulate the blood environment, immune system, and the growth and spreading process of tumor cells in the human body. This makes the research results more informative and practical.
Multiple Inoculation Options
The platform provides a variety of inoculation methods for blood tumor models, including intravenous injection, bone marrow transplantation, etc., to meet different research needs. Researchers can choose the most suitable inoculation method according to the experimental purpose and tumor type, so as to more accurately simulate the pathogenesis of human diseases.
Easy to operate and highly efficient
The inoculation platform of InnoModels Blood Tumor Model System focuses on simplicity and efficiency in operation. The platform adopts advanced automated equipment and intelligent management system, which makes the experimental operation easier and faster, and at the same time improves the experimental efficiency and accuracy.
Strict Quality Control
In the process of blood tumor model preparation, the platform implements strict quality control measures. From cell culture, model construction to experimental inoculation, each step is carefully designed and strictly monitored to ensure the stability and reliability of the model.

Wide range of applications
The platform is not only suitable for basic research on hematological tumors, but can also be applied to drug screening and evaluation of therapeutic effects. Researchers can use the platform to conduct rapid and accurate evaluation of new anticancer drugs, which provides a strong experimental basis for the clinic.
Powerful Technical Support
Behind the inoculation platform of InnoModels' blood tumor modeling system is a professional technical team with rich experimental experience and profound professional knowledge, which can provide researchers with all-round technical support and guidance.
Environmental Protection and Safety
While pursuing scientific breakthroughs, the platform also emphasizes environmental protection and safety. The platform adopts environmentally friendly experimental materials and technical means to reduce the impact of the experimental process on the environment. At the same time, the platform also strengthens the treatment and management of experimental waste to ensure the safety of the experimental process.
In conclusion, with its highly simulated human environment, multiple inoculation options, easy operation, strict quality control, wide range of applications, strong technical support, as well as environmental protection and safety, the inoculation platform of InnoModels Biotechnology Hematology Tumor Modeling System provides powerful support for hematology tumor research. It is believed that with the continuous development and improvement of the technology, the platform will play a greater role in the field of cancer research.
Previous Page
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd